Capital International Investors’s Elevance Health ELV Stock Holding History

Capital International Investors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$308M	Sell	1,050,861 -536,582	-34%	-$176M	0.07%	188
2025 Q4	$556M	Sell	1,587,443 -1,367,274	-46%	-$462M	0.09%	166
2025 Q3	$955M	Sell	2,954,717 -3,533,312	-54%	-$1.1B	0.15%	113
2025 Q2	$2.52B	Buy	6,488,029 +932,142	+17%	+$375M	0.43%	58
2025 Q1	$2.42B	Buy	5,555,887 +1,675,257	+43%	+$673M	0.48%	55
2024 Q4	$1.43B	Buy	3,880,630 +35,576	+0.9%	+$14.9M	0.27%	86
2024 Q3	$2B	Buy	3,845,054 +112,079	+3%	+$59.9M	0.38%	70
2024 Q2	$2.02B	Buy	3,732,975 +234,464	+7%	+$124M	0.42%	63
2024 Q1	$1.81B	Buy	3,498,511 +123,802	+4%	+$61.6M	0.37%	79
2023 Q4	$1.59B	Buy	3,374,709 +248,150	+8%	+$115M	0.36%	77
2023 Q3	$1.36B	Sell	3,126,559 -1,564,746	-33%	-$710M	0.35%	81
2023 Q2	$2.08B	Sell	4,691,305 -155,005	-3%	-$71.5M	0.5%	58
2023 Q1	$2.23B	Sell	4,846,310 -636,068	-12%	-$303M	0.57%	46
2022 Q4	$2.81B	Sell	5,482,378 -1,188,375	-18%	-$603M	0.75%	29
2022 Q3	$3.03B	Buy	6,670,753 +248,354	+4%	+$119M	0.88%	26
2022 Q2	$3.1B	Buy	6,422,399 +150,575	+2%	+$74.5M	0.84%	27
2022 Q1	$3.08B	Buy	6,271,824 +633,661	+11%	+$290M	0.7%	35
2021 Q4	$2.61B	Buy	5,638,163 +437,816	+8%	+$184M	0.55%	44
2021 Q3	$1.94B	Buy	5,200,347 +577,145	+12%	+$219M	0.44%	62
2021 Q2	$1.77B	Buy	4,623,202 +258,720	+6%	+$98.9M	0.4%	70
2021 Q1	$1.57B	Buy	4,364,482 +180,270	+4%	+$58M	0.4%	69
2020 Q4	$1.34B	Sell	4,184,212 -587,828	-12%	-$180M	0.37%	79
2020 Q3	$1.28B	Sell	4,772,040 -2,751,913	-37%	-$740M	0.4%	66
2020 Q2	$1.98B	Sell	7,523,953 -594,186	-7%	-$159M	0.65%	38
2020 Q1	$1.84B	Buy	8,118,139 +1,139,145	+16%	+$310M	0.75%	33
2019 Q4	$2.11B	Buy	6,978,994 +1,298,029	+23%	+$357M	0.72%	33
2019 Q3	$1.36B	Buy	5,680,965 +1,934,596	+52%	+$530M	0.52%	55
2019 Q2	$1.06B	Buy	3,746,369 +2,269,533	+154%	+$620M	0.42%	68
2019 Q1	$424M	Buy	+1,476,836	New	+$427M	0.18%	128

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Capital International Investors's ELV Position: Q1 2026 in Review

Capital International Investors reduced its Elevance Health (ELV) stake by 34% in Q1 2026, selling an estimated $176M and leaving 1,050,861 shares worth $308M. The position accounts for 0.07% of the portfolio, ranked #188.

Capital International Investors first reported a position in ELV in Q1 2019 and has held it in 29 quarters since. The position peaked at $3.1B in Q2 2022. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Capital International Investors held 1,050,861 shares of Elevance Health worth $308M as of Q1 2026.
Capital International Investors sold 536,582 Elevance Health shares in Q1 2026, an estimated $176M.
Elevance Health made up 0.07% of Capital International Investors's portfolio in Q1 2026, its #188 holding.
Capital International Investors first reported a position in Elevance Health in Q1 2019 and has held it in 29 quarters since.
Capital International Investors's Elevance Health position peaked at $3.1B in Q2 2022.
1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capital International Investors's 13F filing for Q1 2026, filed 13 May 2026.